Cargando…
Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury
The prognosis of the liver transplant patients was frequently deteriorated by ischemia and reperfusion injury (IRI) in the liver. Infiltration of inflammatory cells is reported to play critical roles in the pathogenesis of hepatic IRI. Although T lymphocytes, neutrophils and monocytes infiltrated in...
Autores principales: | Yin, Enzhi, Fukuhara, Takeshi, Takeda, Kazuyoshi, Kojima, Yuko, Fukuhara, Kyoko, Ikejima, Kenichi, Bashuda, Hisashi, Kitaura, Jiro, Yagita, Hideo, Okumura, Ko, Uchida, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973783/ https://www.ncbi.nlm.nih.gov/pubmed/33737554 http://dx.doi.org/10.1038/s41598-021-85001-2 |
Ejemplares similares
-
Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury
por: Adachi, Takaomi, et al.
Publicado: (2013) -
A novel immunotoxin reveals a new role for CD321 in endothelial cells
por: Fukuhara, Takeshi, et al.
Publicado: (2017) -
Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice
por: Li, Shaowei, et al.
Publicado: (2017) -
Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody Therapy
por: Takeda, Kazuyoshi, et al.
Publicado: (2004) -
Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development
por: Takeda, Kazuyoshi, et al.
Publicado: (2002)